Goodman Noah has filed 4 insider transactions across 1 company since April 2025.
Most recent transaction: a grant/award of 9225 shares of Kymera Therapeutics, Inc. ($KYMR) on March 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Kymera Therapeutics, Inc. | $KYMR | Goodman Noah | Chief Business Officer | A | Common Stock | 9225 | $0.00 | 59,306.4380 | 87,300,286 | 18.42% | 0.01% |
| March 2, 2026 | Kymera Therapeutics, Inc. | $KYMR | Goodman Noah | Chief Business Officer | A | Stock Option (Right to Buy) | 18450 | $0.00 | 18,450.0000 | 87,300,286 | 9999.99% | 0.02% |
| April 8, 2025 | Kymera Therapeutics, Inc. | $KYMR | Goodman Noah | Chief Business Officer | A | Common Stock | 50000 | $0.00 | 50,081.4380 | 75,043,991 | 9999.99% | 0.07% |
| April 8, 2025 | Kymera Therapeutics, Inc. | $KYMR | Goodman Noah | Chief Business Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 75,043,991 | 9999.99% | 0.13% |